KCNG2

Across TCGA pan-cancer cohorts, KCNG2 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated KCNG2 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher KCNG2 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated KCNG2 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

CESC, KIRP, and COAD are the cancer types where KCNG2 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	II,III,IV	0.095	0.830	<.001	30	view →
KIRP	OS	Median	All	0.636	0.885	.029	3	view →
COAD	DFS	Median	All	1.000	0.506	.033	3	view →
LUAD	OS	Median	All	0.277	0.787	.022	3	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

KCNG2–CESC (OS)

Open the CESC breakdown →